Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug–drug interaction

INTRODUCTION: Erlotinib is a FDA approved small molecule inhibitor of epidermal growth factor receptor and dovitinib is a novel small molecule inhibitor of fibroblast growth factor and vascular endothelial growth factor receptor. This phase 1 trial was conducted to characterize the safety and determ...

全面介紹

Na minha lista:
書目詳細資料
發表在:Lung Cancer
Main Authors: Das, Millie, Padda, Sukhmani K., Frymoyer, Adam, Zhou, Lisa, Riess, Jonathan W., Neal, Joel W., Wakelee, Heather A.
格式: Artigo
語言:Inglês
出版: 2015
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4613811/
https://ncbi.nlm.nih.gov/pubmed/26149476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2015.06.011
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍